New multi-specimen perfusion bioreactor for reliable tissue growth introduced by Bose

Bose Corporation has introduced the 3DCulturePro™ system, a new multi-specimen perfusion bioreactor designed for biologists, biomedical researchers and scientists who require reproducible and reliable tissue growth. The 3DCulturePro system supports cell growth and 3D tissue culture in an easy-to-use, scalable configuration.

Versatile and portable, the Bose® 3D CulturePro bioreactor is built for multiple experiment usage, completely biocompatible and can be moved in and out of standard cell incubators. It can be set up as a single, standalone chamber with specimen fixtures or as a complete, multi-chamber system with a perfusion pump to meet the specific research needs of lab users.

The multi-chamber configuration can hold up to six chambers, which can be positioned vertically, horizontally or on the side to support various applications and experiments. Each chamber comes with barb fittings, porous platens and grips that can be used for different sample sizes and types, including bone, blood vessels, skin, ligaments, tendons or other tissues and biomaterials.

The 3DCulturePro system is also useful for biologists moving from 2D to 3D culture, biomedical engineers moving from static to dynamic culture, as well as pharmacologists and drug development researchers interested in an in vitro test bed or an ex vivo drug delivery testing system.

The 3DCulturePro™ system is available now at two price points: $4,500 (USD) for the single-chamber package or $12,500 (USD) for the multi-chamber package (prices vary by country). Both offerings are backed by Bose® Above & Beyond™ support, which includes application expertise and unlimited technical phone support.

This system joins the comprehensive line of Bose BioDynamic® products that are used within sterile cell culture environments. More complex, single and multi-specimen testing instruments are available from Bose, providing mechanical stimulation to promote tissue growth, along with the ability to characterize biomaterials and biological samples. For more information on these products, visit https://www.bose.com/en_us/index.html.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    TA Instruments. (2023, March 22). New multi-specimen perfusion bioreactor for reliable tissue growth introduced by Bose. News-Medical. Retrieved on May 04, 2024 from https://www.news-medical.net/news/20141112/New-multi-specimen-perfusion-bioreactor-for-reliable-tissue-growth-introduced-by-Bose.aspx.

  • MLA

    TA Instruments. "New multi-specimen perfusion bioreactor for reliable tissue growth introduced by Bose". News-Medical. 04 May 2024. <https://www.news-medical.net/news/20141112/New-multi-specimen-perfusion-bioreactor-for-reliable-tissue-growth-introduced-by-Bose.aspx>.

  • Chicago

    TA Instruments. "New multi-specimen perfusion bioreactor for reliable tissue growth introduced by Bose". News-Medical. https://www.news-medical.net/news/20141112/New-multi-specimen-perfusion-bioreactor-for-reliable-tissue-growth-introduced-by-Bose.aspx. (accessed May 04, 2024).

  • Harvard

    TA Instruments. 2023. New multi-specimen perfusion bioreactor for reliable tissue growth introduced by Bose. News-Medical, viewed 04 May 2024, https://www.news-medical.net/news/20141112/New-multi-specimen-perfusion-bioreactor-for-reliable-tissue-growth-introduced-by-Bose.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.